U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Therapeutics Acquisition Corp.
(Exact Name of Registrant as Specified in Its Charter)
| Delaware | 85-0800493 | |
| (State of Incorporation or Organization) | (I.R.S. Employer Identification No.) | |
|
200 Berkeley Street 18th Floor Boston, MA |
02116 | |
| (Address of Principal Executive Offices) | (Zip Code) | |
Securities to be registered pursuant to Section 12(b) of the Act:
|
Title of Each Class to be Registered |
Name of Each Exchange on Which Each Class is to be Registered |
|
| Common Stock, par value $0.0001 per share | The Nasdaq Stock Market LLC | |
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. x
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. ¨
If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ¨
Securities Act registration statement or Regulation A offering statement file number to which this form relates: 333-239196 (if applicable)
Securities to be registered pursuant to Section 12(g) of the Act:
N/A
(Title of Class)
| Item 1. | Description of Registrant’s Securities to be Registered. |
The securities to be registered hereby are the Class A common stock, par value $0.0001 per share (the “Class A Common Stock”) of Therapeutics Acquisition Corp. (the “Company”). The description of the Class A Common Stock contained in the section entitled “Description of Shares” in the prospectus included in the Company’s Registration Statement on Form S-1 (File No. 333-239196), as amended (the “Registration Statement”), to which this Form 8-A relates, is incorporated herein by reference. Any form of prospectus or prospectus supplement to the Registration Statement that includes such description and that is subsequently filed is also incorporated by reference herein.
| Item 2. | Exhibits. |
Under the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The Nasdaq Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereto duly authorized.
| Very truly yours, | ||
| THERAPEUTICS ACQUISITION CORP. | ||
| By: | /s/ Matthew Hammond | |
| Matthew Hammond | ||
| Chief Financial Officer | ||
Dated: July 7, 2020